Title: Assessment of P- to
delta-wave interval and its relationship with
accessory pathway properties in patients with
pre-excitation
Authors: Osman Can Yontar, Ahmet Yanik, Gokhan
Aksan
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
292–296
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-057
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-057 Background: The first clinical
manifestation of the Wolff– Parkinson–White
syndrome in previously asymptomatic individuals
may be sudden cardiac death. The options for
non-invasive risk stratification are limited in
the current era beyond ambulatory rhythm
monitoring and an exercise stress test. In our
study, we sought to investigate whether there
was a relationship between the shortest measured
P- to delta-wave time interval (PDI) on the
conduction properties of surface
electrocardiogram and accessory pathways
expressed as ante grade effective refractory
period (APERP). Methods: Demographic data,
symptom status, electrocardio grams (ECG) and
intra-cardiac recordings of invasive electro
physiology testing of 103 patients who underwent
accessory pathway ablation procedures were
collected. Exclusion crite ria were: (1)
intermittently occurring pre-excitation, which
was detected in previous ECGs, (2) delta-wave
resolution on treadmill test, (3) presence of
multiple accessory pathways, and (4) accessory
pathway locations other than the septum. The PDI
was measured as the time interval from the begin
ning of the P wave to the earliest upstroke or
downstroke of the delta wave on V1 and V2
derivations of the surface ECG, and the shortest
measurement was recorded. Results: Patients were grouped
into two groups: group I, if APERP was < 240 ms
and group II if APERP was ≥ 240 ms. PDI was
significantly shorter in group II. By
correlation anal ysis, a positive and moderate
correlation between PDI and APERP (r = 0.598, p
< 0.001) and PDI and age (r = 0.800, p < 0.001)
was found, and a negative and moderate
correlation between PDI and inducible AF (r =
–492, p < 0.001). The best cut-off value for PDI
to predict APERP ≥ 240 was 90.5 ms with a
sensitivity of 80% and a specificity of 83%. Conclusion: Our results
demonstrate that there was a strong correlation
between the P- to delta-wave interval and univer
sally accepted risk factors, such as low age,
low APERP and atrial fibrillation inducibility.
Further studies with larger patient groups and
follow-up data are needed to appraise its
predictive value.
Title: Cardiac manifestation of
corona virus disease 2019: a preliminary report
Authors: GT Lasisi, AO Duro-Emanuel, TE
Akintomide, JO Ologunja, OE Amah
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
297–300
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-061
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-061 Background: Corona virus
disease 2019 (COVID-19) is a multi-systemic
illness that can present with cardiac
complications. This report describes the
preliminary findings of cardiac manifestations
seen in patients managed in three centres in
Lagos, Nigeria. Methods: Ten patients, part of
an ongoing study of patients admitted in three
centres in Lagos, Nigeria, with COVID-19
diagnosed with reverse transcriptase polymerase
chain reaction (RT-PCR) or serology were
retrospectively studied for cardiac
manifestations. Results: The mean (SD) age was
52.5 ± 18.79 years (with a minimum of 17 years
and maximum of 79 years). Six patients were
female and four were male. Hypertension was seen
in 70%, diabetes in 50% and obesity in 60% of
patients. All had elevated inflammatory markers.
Only four patients had bilateral pneumonia. The
rest had only cardiac manifestations. Six
patients presented with de novo heart failure
and one had decompensated heart failure. A set
of three patients had individually fulminant
myocarditis, probable pulmonary embolism and
stress cardiomyopathy, respectively. Conclusion: This study shows
that co-morbidities are common in patients with
COVID-19 and cardiac complications. The array of
cardiac complications is large, with the
commonest being heart failure.
Title: Pregnancy in women with
cardiac disease: a one-year retrospective review
of management and maternal and neonatal outcomes
in a tertiary hospital in Johannesburg, South
Africa
Authors: Irina Balieva, Lawrence Chauke, Amy
Wise, Adriaan A Voors, Elise Schapkaitz, Hendrik
Lombaard, Haroun A Rhemtula
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
301–307
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-062
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-062 Introduction: In South Africa,
cardiac disease continues to be the most
important non-obstetric cause of maternal death. Methods: A record review of 74
pregnant women with cardiac disease was
performed to determine the prevalence and
outcomes of cardiac disease at Charlotte Maxeke
Johannesburg Academic Hospital between January
and December 2017. Results: Rheumatic heart
disease was the most common cardiac diagnosis (n
= 21, 28.4%), followed by pulmonary hypertension
(n = 13, 17.6%) and congenital heart disease (n
= 12, 16.2%). There were one (1.4%) maternal and
two (2.7%) perinatal deaths. Neonatal
complications included pre-term delivery (n =
20, 32.3%) and small-for-gestational-age infants
(n = 10, 16.1%). Cardiac complications (n = 30,
40.5%) included heart failure (n = 15, 20.3%),
pulmonary hypertension (n = 11, 14.9%) and blood
transfusions (n = 8, 10.8%). Conclusion: Cardiac disease in
pregnancy was associated with a high risk of
maternal and neonatal complications.
Pre-conceptual counselling and managing pregnant
women at a dedicated centre by a
multidisciplinary team could, however, improve
outcomes.
Title: Factors associated with acute
kidney injury and mortality during cardiac
surgery
Authors: Gontse Leballo, Hlamatsi Jacob
Moutlana, Michel Kasongo Muteba, Palesa Motshabi
Chakane
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
308–313
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-063
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-063 Background: Cardiac surgery
with cardiopulmonary bypass (CPB) is known to
contribute towards the incidence of acute kidney
injury (AKI) and peri-operative morbidity and
mortality. There are several patient,
anaesthetic and surgical factors that contribute
to its occurrence. It is imperative to know the
profile of a patient who is likely to develop
this complication to mitigate for modifiable
risks. This study aimed at describing a profile
of AKI in an adult patient (over the age of 18
years) following cardiac surgery on CPB. Factors
associated with the development of cardiac
surgery-associated acute kidney injury (CSA-AKI)
are described, as well as the relationship
between CSA-AKI and in-hospital mortality. Methods: This was a contextual,
descriptive and retrospective single-centre
study with data of 476 adult patients admitted
post cardiac surgery between January 2016 and
December 2017. Data were collected from
Charlotte Maxeke Johannesburg Academic Hospital
(CMJAH) in South Africa. All adult patients who
presented for elective cardiac surgery (coronary
artery bypass graft), valvular, aortic and other
cardiac surgery on CPB were included.
Peri-operative factors such as patient
demographics, baseline renal function, co-morbid
factors, length of CPB and aortic cross-clamp
time, degree of hypothermia, use of assist
devices, and post-operative serum creatinine
(SCr) levels were collected. Incomplete
essential peri-operative data and data for
patients who presented on renal replacement
therapy (RRT) already were excluded. AKI was
defined by Kidney Disease Improving Global
Outcomes (KDIGO) criteria. Results: One hundred and
thirty-five (28%) patients developed CSA-AKI and
20, 5 and 3% were in KDIGO 1, 2 and 3,
respectively. Older age (p = 0.024), female
gender (p = 0.015), higher serum creatinine
level (p = 0.025), and lower estimated
glomerular filtration rate (eGFR) (p = 0.025)
were associated with the development of CSA-AKI,
while a history of hypertension was predictive.
Forty-six of the 476 patients died. Mortality
rates were significantly higher in those with
AKI compared to those without [28 (21%) vs 18
(5%), respectively (p = 0.001)]. The incidence
was significantly worse in those with severe
kidney injury, as evidenced by mortality rates
of 44 versus 5% between KDIGO 3 and KDIGO 1 (p <
0.001). Pre-operative eGFR and CSA-AKI requiring
RRT were significantly associated with
mortality, while pre-operative eGFR was an
independent predictor of mortality (hazard ratio
0.99, 95% confidence interval: 0.97–0.99, p =
0.019). Conclusion: A history of
hypertension was predictive of the development
of CSA-AKI, and pre-operative eGFR was an
independent predictor of mortality in this
cohort. Both factors are modifiable.
Title: Relationship between P-wave
dispersion, left ventricular mass index and
function in Nigerian hypertensive patients
Authors: Francisca O Inofomoh, Oluranti B
Familoni, Casmir E Amadi
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
314–319
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2021-003
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2021-003 Abstract: Hypertension is the
most prevalent cardiovascular disorder in the
world. It is associated with target-organ damage
in various organs and ECG changes. P-wave
dispersion (PWD), which represents inhomogeneous
atrial conduction and discontinuation of
impulses, has been observed, when prolonged, to
predict atrial fibrillation, particularly in the
setting of hypertension. This study of PWD in
150 hypertensive patients and controls sought to
determine the prevalence of PWD in Nigerian
hypertensives and its relationship to left
ventricular mass index and left ventricular
function. Mean PWD in normal subjects was 32.14
± 4.72 ms and was significantly shorter than
that in hypertensive patients at 38.29 ± 8.02
ms. In the total population, 51.3% had prolonged
PWD (> 33.46 ms); 70% in the hypertensives and
32.7% of controls. The only significant
difference in hypertensives with prolonged and
normal PWD was the waist circumference. There
was a negative correlation between PWD and
ejection fraction (r = –0.17, p = 0.03), but not
with diastolic function.
Title: Clinical and
echocardiographic findings in a crosssectional
study of HIV-infected adults in Enugu, Nigeria
Authors: Paschal O Njoku, Emmanuel C Ejim,
Benedict C Anisiuba, Samuel O Ike, Basden JC
Onwubere
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
320–326
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-065
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-065 Background: Human
immunodeficiency virus (HIV) infection and
highly active antiretroviral therapy (HAART) are
implicated in cardiovascular diseases. The
objective of this study was to evaluate the
clinical and echocardiographic findings in
HIV-infected adults. Methods: One hundred HIV
subjects on HAART, 100 HAART-naïve patients and
100 controls were recruited in this
cross-sectional study. Results: Mean CD4 cell count
was significantly higher in the HAART-exposed
(408.43 ± 221.62) than the HAART-naïve groups
(250.06 ± 154.26) (p < 0.001). Weight loss
(49%), skin lesions (14%), body weakness (24%),
oral thrush (10%) and lymphadenopathy (10%) were
more prevalent in HAARTnaïve patients (p <
0.05). Dimensions of aortic root (2.71 cm), left
atrium (3.27 cm) and left ventricular mass index
(79.95) were significantly higher in
HIV-positive subjects on HAART (p < 0.05). Conclusion: Clinical features
of HIV and the CD4 nadir were more prevalent in
the HIV-positive, HAART-naïve subjects.
Dimensions of the aortic root, left atrium and
left ventricle were relatively larger in the
HAART-exposed patients while wall thickness and
ejection fraction were higher in the HAART-naïve
subjects.
Title: Efficacy of amiodarone for
the prevention of atrial fibrillation recurrence
after cardioversion
Authors: Sabina Istratoaie, Octavia Sabin,
Ștefan C Vesa, Gabriel Cismaru, Valer I Donca,
Anca D Buzoianu
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
327–338
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-060
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-060 Abstract: The restoration and
maintenance of sinus rhythm is a desirable
strategy for many patients with atrial
fibrillation (AF) since it has been associated
with improvement in symptoms and a better
quality of life. Sinus rhythm can be achieved by
pharmacological or electrical cardioversion or
after catheter ablation of AF. Despite high
rates of successful cardioversion, AF recurrence
remains a major challenge. Anti-arrhythmic drug
therapy currently plays a significant role in
maintaining sinus rhythm after cardioversion.
Amiodarone is the most commonly prescribed
anti-arrhythmic drug for patients with AF. This
is due to its particular electrophysiological
properties and superior anti-arrhythmic effects
in comparison with other anti-arrhythmic drugs.
Understanding the cardiac electrophysiology and
arrhythmogenesis mechanisms may result in
identification of new targets for
anti-arrhythmic therapy. The aim of this article
was to review amiodarone’s clinical pharmacology
and evaluate evidence supporting amiodarone for
treatment and prevention of AF recurrence after
cardioversion.
Title: Repetitive use of
levosimendan in clinical practice: a case series
Authors: Michał Wawrzyniak, Jacek Migaj, Ewa
Straburzyńska-Migaj, Magdalena Dudek, Marta
Kałużna-Oleksy
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
339–342
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-058
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-058 Abstract: Levosimendan was
developed as a treatment for acute
decompensation of severe heart failure (HF). Its
use has evolved during recent years, and new HF
treatment strategies in different settings have
been developed. This case series aimed to show
indications for the use of levosimendan and to
discuss the treatment response in various
settings. Repetitive levosimendan infusions were
found to be safe and effective. They seemed to
prolong the time of clinical stability, although
they did not alter the eventual natural history
of HF, with increasing frequency of
hospitalisations and rising natriuretic peptide
levels.
Title: Peri-operative
echocardiography for lung transplantation in a
critical patient with COVID-19
Authors: Yan Chen, Hongxia Wang, Yun Mou, Zhelan
Zheng
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
343–345
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2020-064
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2020-064 Abstract: Critical patients
with coronavirus disease 2019 (COVID-19) suffer
from severe illness and have a high mortality
rate. Lung transplantation may be the final
option for a subset of these patients. Herein we
report the important role of peri-operative
echocardiography in a COVID-19 patient who
underwent bilateral lung transplantation because
of severe respiratory failure. The precise
evaluation provided by echocardiography enabled
the prevention of anastomotic complications and
the successful management of haemodynamic
instability. Echocardiographers should be
familiar with the complications of lung
transplantation and the haemodynamics under
extracorporeal membrane oxygenation support to
achieve a more accurate interpretation of
cardiac parameters.
Title: Challenging paediatric
coarctation cases treated with a hybrid
approach: five-year follow up
Authors: Sonia El-Saiedi, Hossam Hassanein,
Ashraf Abdel-Rahim, Mohamed Maher, Ahmed
Abdel-Wahed, Wael Attia
From: Cardiovascular Journal of Africa, Vol 32,
Issue 6 November/December 2021
Pages:
346–349
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2021-006
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2021-006 Abstract: Two paediatric
patients suffering from recurrent coarctation
after native coarctation surgery were scheduled
for cardiac catheterisation in a hybrid setting
by the age of two and three years. Through a
right anterior mini-thoracotomy, unmounted
stents were successfully placed in the coarctant
segment. One-year follow up did not show
echocardiographic improvement but the patients
were controlled on medical therapy. Five-year
follow up showed stent breakage in the first
case, while the second showed stent stenosis
that needed balloon dilatation.